Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...
Daily Maverick on MSN1d
New chronic kidney disease treatments show promise, but are expensive and inaccessibleWhile the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...
1d
Weight loss drugs like Ozempic deliver more health benefits than expected.
An Australian medical technology company, Proteomics International, has published a study demonstrating a new blood test ...
Chronic Kidney Disease is a silent killer that progresses gradually, often going unnoticed until the late stages. While ...
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback